KOR
전체메뉴 닫기

History

2011

Established a joint venture company with the U.K., Pathway Intermediates International (PII)

2012

Changed company name to EASY BIO SYSTEM to EASY BIO, Inc..

Certified for GMP (EASY BIO, PII)

2013

PII Lipidol® production plant is constructed

A New Goal of Becoming a Global Brand for Feed Additives

After seeing rapid growth in the animal business in South Korea, EASY BIO successfully entered the global market for animal feed, worth 400 billion US dollars  , with its feed additive solution in 2013. The solution is the fruit of EASY BIO’s proprietary technology and knowhow acquired while competing successfully in the South Korean market against multinational firms, and continues to prove to be a success story for EASY BIO. With the launch of the SCBU (Solution Creation Business Unit) in 2013, the company expanded its overseas distribution network and recruited local employees in China, Thailand Vietnam and others to simultaneously push with globalization and localization. In 2016, the local joint venture firm PII Nantong was established in China and U.S.A. During the same year, a joint venture firm Esys Bioferm, Inc.1) was established as part of a move towards equity participation in the Canada-based firm, GNC Bioferm Inc. with whom EASY BIO has had a strategic partnership for over 20 years. This move was made to develop multi-enzymes used in animal feed while growing the company’s business. Since the establishment of the joint venture Pathway Intermediates International2) in 2011, EASY BIO has had a close cooperative relationship with the U.K.-based Pathway Intermediates Limited3), which it later acquired in 2018. This was when EASY BIO started to be more aggressive in investments and M&A’s in the global market. To boost local sales, EASY BIO Thailand3),4) was established in 2017, followed by Pathway Intermediates Vietnam Co., Ltd4) and Pathway Intermediates USA, LLC.3) in 2019. For the Chinese market, a representative office was first set up before establishing a local subsidiary. In 2019, Pathway Intermediates was launched as a global brand for animal nutrition. This allowed all the solutions developed by EASY BIO in South Korea, Canada and U.K. to be supplied to markets around the world under the single brand of Pathway Intermediates for a more efficient brand strategy.

1) 2016, Equity participation in GNC Bioferm, Inc., followed by liquidation.
2) 2019, 100% of equity stake of U.K.-based Pathway Intermediates Limited is acquired.
3) 2020, Became an EASY Holdings’ subsidiary after human resource allocations.
4) 2019, Changed company name to Pathway Intermediates (Thailand) Co., Ltd.

2014

EASY BIO Middle East Office is established.

Certified for FAMI-QS (EASY BIO, PII).

2015

EASY BIO Thailand is established.

2016

PII (Nantong) Bio-Tech Co.,Ltd is established.

2017

Pathway Thailand is established.

2019

Pathway USA is established.

Pathway Vietnam is established.

2020

The company is split (The new company EASY BIO is established.)

2020, A Year for Another Jump Forward

With feed additives (Pathway Intermediates) and specialized piglet feed (I-feed) as key business areas, EASY BIO started anew as a new company on May 1, 2020 by carrying spinoff with the existing corporation of EASY HOLDINGS. This move was made to increase efficiency in the vertically integrated EASY HOLDINGS animal businesses, and to implement aggressive growth strategies in the global market with a focus on competitive business categories of EASY BIO.
The animal industry has grown continuously as one that provides food security and pleasure in life. The 400 billion US dollars  market for animal feed will continue to see at least a 3% per annum growth, thanks to the growth in the economy and population centered around developing countries. It is anticipated that the global market for feed additives will continue to see high growth of 6% per annum to become a market worth more than 44 billion US dollars. The new trends in the animal industry, including the fourth industrial revolution, incorporation, a move towards environment-friendliness, animal welfare and sustainability while moving away from antibiotics, will continue to accelerate the growth of the global animal feed and feed additive industry. EASY BIO seeks to build on its growth by capturing the potential and scalability of the animal resource industry.
Pathway Intermediates, the business division for feed additives, will play a major role in securing sustainability in the industry. By continuing to establish overseas subsidiaries and local production hubs, tailored products will be supplied to key regions. An integrated research network formed by the Bio-Resource Institute in South Korea, the Pathway Research Centre in the U.K. and the Canada-based research institute specializing in enzymes will provide a future growth engine for EASY BIO to become a company known for ‘total solutions’. Strategic investment and M&A’s will also be used to make the company a well-established mid-sized firm in the global additives market by 2025. The company has a vision to become a global leader in the industry by 2030.
The business division for specialized piglet feed, represented by I-feed will further confirm its status as a leader in the animal resource industry in South Korea. The strategy focusing on the superior quality of the products will be reinforced through proactive collaboration between EASY HOLDINGS that have the technologies and knowhow in the animal industry and the infrastructure for the feed additive business of EASY BIO, as well as the multiple years of knowhow. To live up to its reputation as the number one brand for specialized piglet feed in South Korea, the company will expand its production and distribution infrastructure to grow together with the company’s many customers. By mid-2020’s, foray into international markets will be proactively pushed for to become a global partner in success.

2021

Pathway Chengdu is established.

2024

Acquired a U.S. Company Devenish Nutrition LLC.

PRIVACY POLICY

Thank you for visiting EASY BIO's website. The contents of the site can be used for private purposes, and the 'link' and 'data' can be directly stored in PCs. However, the site is bound under certain legal restrictions and prohibitions. The restrictions and prohibitions include the following recognitions:

1. The website is an exclusive information property of EASY BIO.
Properties related to the EASY BIO website (www.easybio.co.kr) include copyrights, trademarks, technology information, pictures, images, sound bites, link, and source codes (mentioned hereafter as 'website service'), and EASY BIO possesses exclusive rights to the website service. All information is provided for the benefit and convenience of EASY BIO's customers.
However, it has to be clarified that EASY BIO is not granting the commercial using rights to the customers. Customers cannot use the website service for any purposes other than for private use.

2. EASY BIO will not be liable for any direct, indirect, incidental, special, or extended damages caused by the website service.
EASY BIO does not deem credible all materials contained in its website. Therefore, unless a special notice is given, EASY BIO's website service should not be used as supplementary information in the decision making process. Apart from the information and service it directly provides in the site, EASY BIO does not guarantee the accuracy, perfection or reliability of additional materials contained in its website. Therefore, we strongly discourage our customers from relying exclusively on information we do not guarantee.
We especially ask you to refrain from using the website for unwarranted sales, trade, and purchase transactions related to the benefits of corporations or individuals. EASY BIO will not be liable for any direct, indirect, incidental, special, or extended damages that results from the use of the information and materials contained in the website.

3. EASY BIO's website service should not be used as materials for securities transactions.
The information and materials contained in the website are not suitable to satisfy the demands and requirements of securities institutions. Therefore, the materials should not be used to make investment decisions. EASY BIO does not guarantee the reliability and credibility of materials in its website as sources for commercial and financial information.

4. The links in EASY BIO's website have no direct connection with EASY BIO
EASY BIO is providing various links in its website that are based on the individual needs of its users. Even though the links are provided for the information gathering and convenience of the users, EASY BIO is not legally responsible for any of the link sites and does not guarantee their credibility. The use of the sites is up to the discretion of each individual.

EASY BIO.